Anton D Pospelov (Anton Pospelov)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Single Molecule

Childhood Cancer

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Olga M Kutova, Anton D Pospelov, Irina V Balalaeva
The Multifaceted Role of Connexins in Tumor Microenvironment Initiation and Maintenance. Biology 12 (2) (2023)
Olga M Kutova, Anton D Pospelov, Irina V Balalaeva
The Multifaceted Role of Connexins in Tumor Microenvironment Initiation and Maintenance. Biology 12 (2) (2023)
Olga M Kutova, Anton D Pospelov, Irina V Balalaeva
The Multifaceted Role of Connexins in Tumor Microenvironment Initiation and Maintenance. Biology 12 (2) (2023)
Anton D Pospelov, Olga M Kutova, Yuri M Efremov, Albina A Nekrasova, Daria B Trushina, Sofia D Gefter, Elena I Cherkasova, Lidia B Timofeeva, Peter S Timashev, Andrei V Zvyagin, Irina V Balalaeva
Breast Cancer Cell Type and Biomechanical Properties of Decellularized Mouse Organs Drives Tumor Cell Colonization. Cells 12 (16) (2023)
Ludmila M Sencha, Olga E Dobrynina, Anton D Pospelov, Evgenii L Guryev, Nina N Peskova, Anna A Brilkina, Elena I Cherkasova, Irina V Balalaeva
Real-Time Fluorescence Visualization and Quantitation of Cell Growth and Death in Response to Treatment in 3D Collagen-Based Tumor Model. International journal of molecular sciences 23 (16) (2022)
Olga M Kutova, Ludmila M Sencha, Anton D Pospelov, Olga E Dobrynina, Anna A Brilkina, Elena I Cherkasova, Irina V Balalaeva
Comparative Analysis of Cell-Cell Contact Abundance in Ovarian Carcinoma Cells Cultured in Two- and Three-Dimensional In Vitro Models. Biology 9 (12) (2020)
Evgeniya Sokolova, Olga Kutova, Alena Grishina, Anton D Pospelov, Evgeniy Guryev, Alexey A Schulga, Sergey Deyev, Irina Balalaeva
Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin. Pharmaceutics 11 (5) (2019)